业界动态国内医卫资讯
抗体药物偶联物（ADC）在非小细胞肺癌（NSCLC）治疗中或优于传统化疗
Medscape News · 2026-11-05 21:43
摘要
一项3期试验评估抗体药物偶联物联合帕博利珠单抗对比化疗联合帕博利珠单抗作为PD-L1阴性晚期非小细胞肺癌患者一线治疗的效果。Medscape Medical News
English
ADC May Beat Conventional Chemotherapy in NSCLC
A phase 3 trial evaluates an antibody-drug conjugate plus pembrolizumab vs chemotherapy plus pembrolizumab as first-line treatment for patients with PD-L1-negative advanced non-small cell lung cancer. Medscape Medical News